Prognostic factors and prevention of radioembolization-induced liver disease.

  title={Prognostic factors and prevention of radioembolization-induced liver disease.},
  author={Belen Gil-Alzugaray and Ana Chopitea and Mercedes I{\~n}arrairaegui and J. I. Bilbao and Macarena Rodr{\'i}guez-Fraile and Javier Saiz Rodr{\'i}guez and A. Calvo Benito and In{\'e}s M B Dom{\'i}nguez and Delia D'Avola and Jos{\'e} Ignacio Herrero and J. Quiroga and Jes{\'u}s Prieto and Bruno Sangro},
  volume={57 3},
UNLABELLED Radioembolization (RE)-induced liver disease (REILD) has been defined as jaundice and ascites appearing 1 to 2 months after RE in the absence of tumor progression or bile duct occlusion. Our aims were to study the incidence of REILD in a large cohort of patients and the impact of a series of changes introduced in the processes of treatment design, activity calculation, and the routine use of ursodeoxycholic acid and low-dose steroids (modified protocol). Between 2003 and 2011, 260… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 75 extracted citations


Publications referenced by this paper.
Showing 1-10 of 24 references

Similar Papers

Loading similar papers…